LATE POSTPANCREATICODUODENECTOMY HEMORRHAGE: INCIDENCE, RISK FACTORS, MANAGEMENT AND OUTCOME
- PMID: 36445230
- DOI: 10.1097/SHK.0000000000001999
LATE POSTPANCREATICODUODENECTOMY HEMORRHAGE: INCIDENCE, RISK FACTORS, MANAGEMENT AND OUTCOME
Abstract
Background:Postpancreaticoduodenectomy (PD) hemorrhage (PPH) is a life-threatening complication after PD. The main objective of this study was to evaluate incidence and factors associated with late PPH as well as the management strategy and outcomes. Methods: Between May 2017 and March 2020, clinical data from 192 patients undergoing PD were collected prospectively in the CHIRPAN Database (NCT02871336) and retrospectively analyzed. In our institution, all patients scheduled for a PD are routinely admitted for monitoring and management in intensive/intermediate care unit (ICU/IMC). Results: The incidence of late PPH was 17% (32 of 192), whereas the 90-day mortality rate of late PPH was 19% (6 of 32). Late PPH was associated with 90-day mortality (P = 0.001). Using multivariate analysis, independent risk factors for late PPH were postoperative sepsis (P = 0.036), and on day 3, creatinine (P = 0.025), drain fluid amylase concentration (P = 0.023), lipase concentration (P < 0.001), and C-reactive protein (CRP) concentration (P < 0.001). We developed two predictive scores for PPH occurrence, the PANCRHEMO scores. Score 1 was associated with 68.8% sensitivity, 85.6% specificity, 48.8% predictive positive value, 93.2% negative predictive value, and an area under the receiver operating characteristic curves of 0.841. Score 2 was associated with 81.2% sensitivity, 76.9% specificity, 41.3% predictive positive value, 95.3% negative predictive value, and an area under the receiver operating characteristic curve of 0.859. Conclusions: Routine ICU/IMC monitoring might contribute to a better management of these complications. Some predicting factors such as postoperative sepsis and biological markers on day 3 should help physicians to determine patients requiring a prolonged ICU/IMC monitoring.
Copyright © 2022 by the Shock Society.
Conflict of interest statement
The author reports no conflicts of interest.
References
-
- Narayanan S, Martin AN, Turrentine FE, Bauer TW, Adams RB, Zaydfudim VM: Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death. J Surg Res 231:304–308, 2018.
-
- Turrini O, Moutardier V, Guiramand J, Lelong B, Bories E, Sannini A, Magnin V, Viret F, Blache JL, Giovannini M, et al.: Hemorrhage after duodenopancreatectomy: impact of neoadjuvant radiochemotherapy and experience with sentinel bleeding. World J Surg 29(2):212–216, 2005.
-
- Lu J-W, Ding H-F, Wu X-N, Liu X-M, Wang B, Wu Z, Lv Y, Zhang X-F: Intra-abdominal hemorrhage following 739 consecutive pancreaticoduodenectomy: risk factors and treatments. J Gastroenterol Hepatol 34(6):1100–1107, 2019.
-
- Hamon A, Mokart D, Pouliquen C, de Guibert JM, Cambon S, Nguyen Duong L, Lambaudie E, Sannini A, Chow-Chine L, et al.: Intraoperative hemorrhagic shock in cancer surgical patients: short and long-term mortality and associated factors. Shock 54:659–666, 2020.
-
- Tien Y-W, Lee P-H, Yang C-Y, Ho M-C, Chiu Y-F: Risk factors of massive bleeding related to pancreatic leak after pancreaticoduodenectomy. J Am Coll Surg 201(4):554–559, 2005.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous